2002-06-21
New treatment modalities and pharmacologic refinements for metatstatic breast cancer
Publication
Publication
Nieuwe cytotoxische behandelingen en farmacokinetiek van paclitaxel bij de gemetastaseerd mammacarcinoom
In this thesis the results of clinical studies with new chemotherapeutic agents and pharmacokinetic studies on taxanes in breast cancer patients are reported. In metastatic breast cancer, endocrine and cytotoxic treatment often result in objective tumor responses, associated with relevant relief of symptoms. At present, however, metastatic breast cancer is still considered to be incurable even despite agressive multi-modality treatment options. Chemotherapy for metastatic breast cancer should therefore aim at a maximum of palliation and prolongation of life, at the cost of a minimal of toxicity.
| Additional Metadata | |
|---|---|
| , , , | |
| Erasmus MC: University Medical Center Rotterdam | |
| J. Verweij (Jaap) | |
| hdl.handle.net/1765/31948 | |
| Organisation | Erasmus MC: University Medical Center Rotterdam |
|
Smorenburg, C. (2002, June 21). New treatment modalities and pharmacologic refinements for metatstatic breast cancer. Retrieved from http://hdl.handle.net/1765/31948 |
|
| Additional Files | |
|---|---|
| Cover.pdf , 197kb | |
| 1848_Smorenburg, Carolina Henriette.jpg Cover Image , 36kb | |
| stellingen Smorenburg.pdf , 25kb | |
